209 related articles for article (PubMed ID: 31482519)
1. Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use.
Chen KTJ; Anantha M; Leung AWY; Kulkarni JA; Militao GGC; Wehbe M; Sutherland B; Cullis PR; Bally MB
Drug Deliv Transl Res; 2020 Feb; 10(1):202-215. PubMed ID: 31482519
[TBL] [Abstract][Full Text] [Related]
2. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a novel flavopiridol formulation for treatment of acute myeloid leukemia.
Chen KTJ; Militao GGC; Anantha M; Witzigmann D; Leung AWY; Bally MB
J Control Release; 2021 May; 333():246-257. PubMed ID: 33798663
[TBL] [Abstract][Full Text] [Related]
4. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
5. Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes.
Rezaei-Sadabady R; Eidi A; Zarghami N; Barzegar A
Artif Cells Nanomed Biotechnol; 2016; 44(1):128-34. PubMed ID: 24959911
[TBL] [Abstract][Full Text] [Related]
6. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
Thomas AM; Kapanen AI; Hare JI; Ramsay E; Edwards K; Karlsson G; Bally MB
J Control Release; 2011 Mar; 150(2):212-9. PubMed ID: 21094191
[TBL] [Abstract][Full Text] [Related]
7. Development of a copper-clioquinol formulation suitable for intravenous use.
Wehbe M; Malhotra AK; Anantha M; Lo C; Dragowska WH; Dos Santos N; Bally MB
Drug Deliv Transl Res; 2018 Feb; 8(1):239-251. PubMed ID: 29247315
[TBL] [Abstract][Full Text] [Related]
8. DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation.
Leung AWY; Chen KTJ; Ryan GM; Anantha M; Wretham N; Nosrati Z; Heroux D; Wang L; Chow N; Dai Z; Bally MB
J Control Release; 2022 May; 345():75-90. PubMed ID: 35259461
[TBL] [Abstract][Full Text] [Related]
9. Optimization of liposomal topotecan for use in treating neuroblastoma.
Chernov L; Deyell RJ; Anantha M; Dos Santos N; Gilabert-Oriol R; Bally MB
Cancer Med; 2017 Jun; 6(6):1240-1254. PubMed ID: 28544814
[TBL] [Abstract][Full Text] [Related]
10. Copper-topotecan complexation mediates drug accumulation into liposomes.
Taggar AS; Alnajim J; Anantha M; Thomas A; Webb M; Ramsay E; Bally MB
J Control Release; 2006 Aug; 114(1):78-88. PubMed ID: 16842880
[TBL] [Abstract][Full Text] [Related]
11. A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
Ramsay E; Alnajim J; Anantha M; Zastre J; Yan H; Webb M; Waterhouse D; Bally M
Eur J Pharm Biopharm; 2008 Mar; 68(3):607-17. PubMed ID: 17904831
[TBL] [Abstract][Full Text] [Related]
12. Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development.
Wehbe M; Anantha M; Backstrom I; Leung A; Chen K; Malhotra A; Edwards K; Bally MB
PLoS One; 2016; 11(4):e0153416. PubMed ID: 27055237
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.
Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT
Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878
[TBL] [Abstract][Full Text] [Related]
14. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models.
Yuan ZP; Chen LJ; Fan LY; Tang MH; Yang GL; Yang HS; Du XB; Wang GQ; Yao WX; Zhao QM; Ye B; Wang R; Diao P; Zhang W; Wu HB; Zhao X; Wei YQ
Clin Cancer Res; 2006 May; 12(10):3193-9. PubMed ID: 16707620
[TBL] [Abstract][Full Text] [Related]
15. Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo.
Tardi PG; Gallagher RC; Johnstone S; Harasym N; Webb M; Bally MB; Mayer LD
Biochim Biophys Acta; 2007 Mar; 1768(3):678-87. PubMed ID: 17208196
[TBL] [Abstract][Full Text] [Related]
16. Quercetin-Decorated Curcumin Liposome Design for Cancer Therapy: In-Vitro and In-Vivo Studies.
Ravichandiran V; Masilamani K; Senthilnathan B; Maheshwaran A; Wong TW; Roy P
Curr Drug Deliv; 2017; 14(8):1053-1059. PubMed ID: 27572089
[TBL] [Abstract][Full Text] [Related]
17. Aqueous injection of quercetin: An approach for confirmation of its direct in vivo cardiovascular effects.
Porcu EP; Cossu M; Rassu G; Giunchedi P; Cerri G; Pourová J; Najmanová I; Migkos T; Pilařová V; Nováková L; Mladěnka P; Gavini E
Int J Pharm; 2018 Apr; 541(1-2):224-233. PubMed ID: 29474897
[TBL] [Abstract][Full Text] [Related]
18. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
Krishna R; Webb MS; St Onge G; Mayer LD
J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
[TBL] [Abstract][Full Text] [Related]
19. Formulation and characterization of liposomes containing drug absorption enhancers for optimized anti-HIV and antimalarial drug delivery.
Kheoane PS; Enslin GM; Tarirai C
Drug Deliv Transl Res; 2023 May; 13(5):1358-1371. PubMed ID: 36443635
[TBL] [Abstract][Full Text] [Related]
20. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
Tran TH; Guo Y; Song D; Bruno RS; Lu X
J Pharm Sci; 2014 Mar; 103(3):840-52. PubMed ID: 24464737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
